Eurofins (via Eurofins Clinical Testing Lux) Acquires Genetic Testing Service JSC (Gentis) in Vietnam

Eurofins Acquires Genetic Testing Service JSC (Gentis) in Vietnam

February 9, 2022

Healthcare Services

Eurofins Scientific, via its subsidiary Eurofins Clinical Testing Lux Sarl, has acquired Genetic Testing Service JSC (Gentis), a leading provider of specialised genetic and clinical testing in Vietnam. The acquisition expands Eurofins' clinical diagnostics footprint in Southeast Asia and adds Gentis' genetic testing capabilities and customer relationships with hospitals and consumers.

Eurofins Scientific Acquires Genetic Lab Co.,Ltd. (G Lab) in Japan

December 10, 2021

Healthcare Services

Eurofins Scientific has entered into a share purchase agreement to acquire Genetic Lab Co.,Ltd. (“G Lab”), a molecular biology-based testing provider in Japan. The acquisition is intended to strengthen Eurofins’ expansion in Asia and enhance its clinical and genetic testing capabilities, including COVID-19 PCR testing and biomarker development support for drug discovery and companion drugs.

Eurofins to Acquire DNA Diagnostics Center (DDC) to Expand Consumer Genetic Testing

June 28, 2021

Biotechnology

Eurofins Scientific, via its subsidiary Eurofins Clinical Testing US Holdings, has entered into an agreement to acquire DNA Diagnostics Center (DDC), a consumer-focused DNA testing laboratory. The deal is expected to expand Eurofins’ reach into consumer genetics and health & wellness markets, with DDC projected to generate over $55M in 2021 revenue and operating from its Fairfield, Ohio facility.

Eurofins Scientific Acquires Infinity Laboratories

September 16, 2024

Healthcare Services

Eurofins Scientific has completed the acquisition of Infinity Laboratories, a U.S.-based contract testing group that operates eight laboratories and employs approximately 100 staff. The deal expands Eurofins' microbiology and package testing footprint across the United States, enhancing its BioPharma and Medical Device testing capabilities and geographic coverage.

Eurofins Scientific Acquires Majority Stake in LifeCodexx

July 27, 2017

Biotechnology

Eurofins Scientific has acquired a 62.63% stake in LifeCodexx AG from GATC Biotech AG, strengthening Eurofins' non-invasive prenatal testing (NIPT) capabilities. LifeCodexx, headquartered in Constance, Germany, is a developer of the PrenaTest NIPT and generated approximately EUR 7m in revenue in 2016.

Eurofins Scientific Acquires bioskin GmbH

August 4, 2021

Healthcare Services

Eurofins Scientific has completed the acquisition of bioskin GmbH, a Hamburg-based dermatology-focused CRO that provides clinical trials for drugs, medical devices, food supplements and advanced cosmetics. The deal expands Eurofins' clinical study management and dermatology capabilities in Germany and strengthens its Cosmetics & Personal Care testing offering.